Clinical Trial Update: Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible) [NA]

View source ↗

Summary

The MAGENTA clinical trial (NCT02993068) sponsored by MD Anderson Cancer Center is suspended; it investigates hereditary gene mutations and receptor-negative br…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: BARD1 Gene Mutation, BRCA1 Gene Mutation | NA | Status: SUSPENDED